Achievement of the National Psoriasis Foundation Treatment Treat-to-Target Goals in the US Ixekizumab Customer Support Program

Main Article Content

Alice Gottlieb
Russel Burge
William Malatestinic
Baojin Zhu
Yunyang Zhao
Julie McCormack
Miriam Kimel
Meghan Feely
Joseph Merola


Psoriasis, treat-to-target, real-world evidence, ixekizumab


1. Armstrong AW, et al. J Am Acad Dermatol. 2017;76(2):290-8

2. Armstrong A, et al. J Am Acad Dermatol. 2021; 85(2): 330-336

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>